发明申请
US20090036493A1 Benzimidazole Derivatives and Their Use for Modulating the GABA Alpha Receptor Complex
失效
苯并咪唑衍生物及其用于调节GABAα受体复合物的用途
- 专利标题： Benzimidazole Derivatives and Their Use for Modulating the GABA Alpha Receptor Complex
- 专利标题（中）： 苯并咪唑衍生物及其用于调节GABAα受体复合物的用途
-
申请号： US11887780申请日： 2006-04-07
-
公开(公告)号： US20090036493A1公开(公告)日： 2009-02-05
- 发明人: Janus S. Larsen , Lene Teuber , Philip K. Ahring , Elsebet Ostergaard Nielsen , Naheed Mirza
- 申请人： Janus S. Larsen , Lene Teuber , Philip K. Ahring , Elsebet Ostergaard Nielsen , Naheed Mirza
- 优先权： DKPA200500530 20050413
- 国际申请： PCT/EP2006/061417 WO 20060407
- 主分类号： A61K31/4439
- IPC分类号： A61K31/4439 ; C07D403/02 ; C07D277/20 ; C07D401/02 ; A61P25/18 ; A61P25/24 ; A61P25/28 ; A61K31/4184 ; A61K31/427
摘要：
This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith.The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex, and in particular for combating anxiety and related diseases.
公开/授权文献
信息查询
IPC分类:
